Aller au contenu principal
Profil bibliographique

Sung Joo Jang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées
34Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Gastric Cancer Management and OutcomesColorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsGenetic factors in colorectal cancerHippo pathway signaling and YAP/TAZ

Les publications récentes

2026 conference-abstract OpenAlex

Comprehensive clinicogenomic profiling of mucinous carcinomas of the gastrointestinal tract.

Lawrence W. Wu, Jimyung Park, Sung Joo Jang, Ryan H. Moy

e15205 Background: Mucinous carcinoma (MC) is a rare, aggressive histological subtype of adenocarcinoma that is associated with poor prognosis and peritoneal spread. Molecular features of MC across gastrointestinal (GI) primary sites remain incompletely defined. Utilizing the American Association for Cancer Research (AACR) …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 conference-abstract OpenAlex

Pan-cancer landscape of oncogenic POLE and POLD1 alterations.

Lawrence W. Wu, Jimyung Park, Sung Joo Jang, Ryan H. Moy

2650 Background: POLE and POLD1 encode key enzymes for DNA proofreading. Oncogenic alterations in POLE and POLD1 associated with defective proofreading can lead to tumor hypermutation and increased sensitivity to immune checkpoint inhibition. Prior studies have identified enrichment of POLE and POLD1 …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2026 preprint OpenAlex

Lung endothelial niche signaling governs self-renewal and fate transitions of human alveolar stem cells

Bang-Jin Kim, Dasom Hwang, Jimyung Park, Sung Joo Jang et autres

Abstract Chronic lung diseases such as pulmonary fibrosis are characterized by the irreversible loss of alveolar type 1 (AT1) cells, yet the mechanisms governing human alveolar stem cell self-renewal and differentiation remain poorly defined. Here, we identify a lung endothelial niche that …

us (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2026 conference-abstract OpenAlex

Comparative analysis of potentially actionable genomic alterations in early-onset versus later-onset gastrointestinal cancers.

Lawrence Wen Wu, Jimyung Park, Sung Joo Jang, Ryan H. Moy

846 Background: There is an alarming rise in early-onset (EO) gastrointestinal (GI) cancers, which may have distinct genomic profiles compared with later-onset (LO) cases. OncoKB is a validated database that provides evidence-based annotation of genomic alterations with therapeutic relevance. Utilizing the American …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Multi-omic characterization of early-onset esophagogastric cancer

Lawrence Wen Wu, Sachin Kumar Deshmukh, Sharon K. Wu, Joanne Xiu et autres

Using a large real-world database with matched genomic and transcriptomic data, we characterized clinical and molecular differences between patients with early-onset esophagogastric cancer (EOEGC; <50 years), intermediate-onset esophagogastric cancer (IOEGC; 50-65 years), and average-onset esophagogastric cancer (AOEGC; >65 years). We analyzed clinicopathologic, …

us (code pays fourni par la source)

5 citations npj Precision Oncology
2025 conference-abstract OpenAlex

Abstract 6942: Targeting CCNE1 amplification in gastric cancer

Sung Joo Jang, Lawrence Wen Wu, Sho Hangai, Cameron Shapiro et autres

Abstract Background: Cyclin E (CCNE1) is amplified in multiple cancers including approximately 10% of esophagogastric cancers and 20% of ovarian cancers. CCNE1 amplification leads to DNA replication stress and chromosomal instability. Prior studies have found that CCNE1 amplification in gastric cancer is …

us (code pays fourni par la source)

0 citations Cancer Research
2025 conference-abstract OpenAlex

Abstract 6918: TEAD inhibition as a therapeutic strategy for diffuse-type gastric cancer

Lawrence Wen Wu, Sung Joo Jang, Jimyung Park, Cameron Shapiro et autres

Abstract Introduction: Diffuse-type gastric cancer (DGC) accounts for one third of gastric cancers and is associated with poor differentiation, discohesive growth, chemoresistance, and worse survival compared to intestinal-type tumors. DGC is typically genomically stable, and there are no approved DGC-targeted therapies. Recent …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2024 article OpenAlex

Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics

Lawrence Wen Wu, Sung Joo Jang, Cameron Shapiro, Ladan Fazlollahi et autres

Diffuse-type gastric cancer (DGC) accounts for approximately one-third of gastric cancer diagnoses but is a more clinically aggressive disease with peritoneal metastases and inferior survival compared with intestinal-type gastric cancer (IGC). The understanding of the pathogenesis of DGC has been relatively limited …

us (code pays fourni par la source)

29 citations Targeted Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.